XOEX - ETF AI Analysis
Top Page
Xtrackers S&P 100 Ex Top 20 ETF (XOEX)
Rating:72Outperform
Price Target:―
Positive Factors
Broad Sector Diversification
The fund spreads its investments across many sectors, which helps reduce the impact if any single industry runs into trouble.
Strong Performance from Key Holdings
Several of the largest positions, especially in technology, health care, and industrials, have delivered strong gains so far this year, supporting the ETF’s overall results.
Low Expense Ratio
The ETF’s relatively low annual fee means more of the fund’s returns stay in investors’ pockets over time.
Negative Factors
Heavy U.S. Concentration
Almost all of the fund’s assets are invested in U.S. companies, offering little diversification across global markets.
Sector Tilts Toward Financials and Health Care
Large weights in financial and health care stocks mean the fund could be more sensitive if those sectors face a downturn.
Recent Short-Term Weakness
The ETF has shown slightly negative performance over the past month, which may signal some short-term volatility despite its stronger year-to-date results.
XOEX vs. SPDR S&P 500 ETF (SPY)
AUM292.93M
RegionNorth America
Expense Ratio0.15%
Beta0.73
IssuerXtrackers
Inception DateNov 09, 2022
Dividend Yield1.42%
Asset ClassEquity
Index TrackedS&P 100 Ex-Top 20 Select Index - USD - Benchmark TR Gross
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume129,582
30 Day Avg. Volume75,389
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
48.19Price Target Upside― Downside
Rating ConsensusStrong Buy
Number of Analyst Covering81
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
XOEX Summary
XOEX is an ETF that follows the S&P 100 Ex-Top 20 Select Index, meaning it invests in many of the largest U.S. companies but leaves out the very biggest 20 names. It spreads your money across several sectors like financials, health care, technology, and industrials. Well-known holdings include AbbVie, Mastercard, Bank of America, Chevron, and Procter & Gamble. Someone might invest in XOEX to get broad, diversified exposure to strong U.S. blue-chip companies beyond the usual mega-cap names. A key risk is that its value can rise or fall with the overall stock market, so your investment is not guaranteed.
How much will it cost me?The Xtrackers S&P ESG Value ETF (Ticker: SNPV) has an expense ratio of 0.15%, meaning you’ll pay $1.50 per year for every $1,000 invested. This is lower than average because the fund is passively managed, tracking the S&P 500 ESG Value Index rather than relying on active stock-picking strategies.
What would affect this ETF?The Xtrackers S&P ESG Value ETF (SNPV) could benefit from growing interest in sustainable investing and the strong performance of large-cap technology companies like Apple and Microsoft, which are its top holdings. However, potential risks include economic slowdowns that could impact the financial and energy sectors, as well as regulatory changes affecting ESG criteria or large-cap companies in the U.S. market.
XOEX Top 10 Holdings
This ETF leans heavily on U.S. large caps, with a clear tilt toward health care, tech, and financials rather than the usual mega-cap tech giants. Lam Research and Applied Materials have been the real engines lately, riding the AI and semiconductor wave, while Palantir has surged recently but remains more of a wild card with mixed signals over the year. AbbVie and Merck provide steady, rising health care ballast, and Bank of America adds a solid, if slower-moving, financial backbone. Overall, performance is driven by a mix of AI-fueled growth and dependable blue-chip strength.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Mastercard | 2.98% | $8.66M | $507.39B | -0.86% | 75 Outperform | |
| AbbVie | 2.89% | $8.41M | $453.19B | 20.65% | 66 Neutral | |
| Bank of America | 2.61% | $7.60M | $438.31B | 25.94% | 72 Outperform | |
| Palantir Technologies | 2.55% | $7.43M | $418.93B | 13.86% | 74 Outperform | |
| Chevron | 2.49% | $7.26M | $412.15B | 35.75% | 71 Outperform | |
| Lam Research | 2.45% | $7.13M | $384.97B | 198.83% | 77 Outperform | |
| Caterpillar | 2.39% | $6.95M | $374.15B | 92.38% | 76 Outperform | |
| Merck & Company | 2.37% | $6.90M | $370.89B | 77.46% | 80 Outperform | |
| Applied Materials | 2.30% | $6.70M | $360.86B | 179.39% | 77 Outperform | |
| UnitedHealth | 2.30% | $6.70M | $356.47B | 25.92% | 72 Outperform |
XOEX Technical Analysis
Positive
―
Price Trends
40.95
Positive
39.86
Positive
38.10
Positive
Market Momentum
0.20
Positive
52.66
Neutral
39.66
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For XOEX, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 41.73, equal to the 50-day MA of 40.95, and equal to the 200-day MA of 38.10, indicating a neutral trend. The MACD of 0.20 indicates Positive momentum. The RSI at 52.66 is Neutral, neither overbought nor oversold. The STOCH value of 39.66 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for XOEX.
XOEX Peer Comparison
Comparison Results
Performance Comparison
XOEX
Xtrackers S&P 100 Ex Top 20 ETF
41.55
7.95
23.66%
IUS
Invesco RAFI Strategic US ETF
―
―
―
CVLC
Calvert US Large-Cap Core Responsible Index ETF
―
―
―
FTQI
First Trust Hedged BuyWrite Income ETF
―
―
―
SPHB
Invesco S&P 500 High Beta ETF
―
―
―
INFO
Harbor PanAgora Dynamic Large Cap Core ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents